Regorafenib in Chinese patients with metastatic colorectal cancer: Subgroup analysis of the phase 3 CONCUR trial.
Xu J, Xu RH, Qin S, Pan H, Bai Y, Chi Y, Wang L, Bi F, Cheng Y, Liu T, Ma D, Shen L, Ba Y, Liang J, Wang X, Yau TCC, Ma BB, Yeh KH, Lin JK, Kappeler C, Shapiro J, Kalmus J, Li J.
Xu J, et al. Among authors: kalmus j.
J Gastroenterol Hepatol. 2020 Aug;35(8):1307-1316. doi: 10.1111/jgh.14974. Epub 2020 Jan 28.
J Gastroenterol Hepatol. 2020.
PMID: 31900959
Free PMC article.